Background: Analysis of global changes in gene transcription and translation by systems-based genomics and proteomics approaches provides only indirect information about protein function. In many cases, enzymatic activity fails to correlate with transcription or translation levels. Therefore, a direct method for broadly determining activities of an entire class of enzymes on a genome-wide scale would be of great utility.
Introduction
New approaches for studying global cellular processes must permit the analysis of differential changes within large sets of known and unknown genes or proteins. DNA microarray techniques allow analysis of genomewide changes in mRNA transcription for a given cellular stimulus [1, 2] . Advances in two-dimensional (2D) gel electrophoresis coupled to highly sensitive mass spectrometry techniques now allow the rapid identi¢cation of proteins from whole cells or tissue extracts [3, 4] . While these techniques have revolutionized the global analysis of biological processes, often information about function of enzymatic proteins can only be inferred by analysis of transcriptional/ translational co-regulation of sets of genes under different stimuli. In fact, levels of transcription and translation of an enzyme, in many cases, do not correlate with its activity [5] .
To assign a function to enzymatic proteins on a genomewide scale, a method to obtain direct information about enzymatic activity is necessary. Since the simultaneous targeting of all enzyme classes with a single probe is likely to be impossible, we chose to focus our effort on proteolytic enzymes. The papain family of cysteine proteases serves as a good model system for several reasons. Firstly, most cysteine proteases are synthesized with an inhibitory propeptide that must be proteolytically removed to activate the enzyme [6, 7] , resulting in expression pro¢les that do not directly correlate with activity. Secondly, the largest set of papain-like cysteine proteases, the cathepsins, act in concert to digest a protein substrate. Thus, information regarding regulation of activity of each member relative to one another is critical for understanding their collective function. Furthermore, the cathepsins are involved in many critical biological processes, and biochemical studies of function have been limited to family members that have been cloned and expressed or puri¢ed from crude tissue. Finally, a large body of information is available regarding covalent, mechanism-based inhibitors that speci¢cally target this family of cysteine proteases.
The papain family is classi¢ed into several major groups, most notable of which are the bleomycin hydrolases, calpains, caspases and cathepsins. To date, 16 human cathepsins have been cloned and sequenced. Several of these proteases are key players in normal physiological processes such as antigen presentation [8] , bone remodeling [9] and prohormone processing [10] . In addition, several of these proteases are involved in pathological processes such as rheumatoid arthritis [11] , cancer invasion and metastasis [12] and Alzheimer's disease [13, 14] .
The enzymatic mechanism used by the papain family of proteases has been well studied and is highly conserved. Thus, electrophilic substrate analogs that are only reactive in the context of this conserved active site can be used as general probes of function. A wide range of electrophiles has been developed as mechanism-based, cysteine protease inhibitors including diazomethyl ketones [15] , £uo-romethyl ketones [16] , acyloxymethyl ketones [17] , O-acylhydroxylamines [18] , vinyl sulfones [19] and epoxysuccinic derivatives [20] . These inhibitors all consist of a peptide speci¢city determinant attached to an electrophile that becomes irreversibly alkylated when bound in close proximity to an attacking nucleophile.
Several groups have recognized the value of using irreversible mechanism-based inhibitors as af¢nity labels [21^25] . Addition of a reporter function, such as a radioactive iodine, to inhibitors permits the visualization of covalently modi¢ed proteases in a standard SDS^PAGE gel format. Labeling intensity provides a read-out of relative enzymatic activity. Furthermore, both known and novel proteases are targets for analysis by this methodology. Similar af¢nity labeling approaches have been used extensively to study or identify proteases such as the proteasome [22, 26, 27] , caspases [28, 29] , cathepsins [23, 25] and methionine amino peptidase [30, 31] . Recently, Cravatt and coworkers have taken advantage of the broad class-speci¢c reactivity of £uorophosphonates towards serine proteases [32] . By incorporation of a simple, extended alkyl chain capped with a biotin moiety, they have created a broad serine protease-speci¢c probe (FP-Biotin) for functional proteomic analysis of serine proteases in crude cellular extracts.
We have developed functional proteomics tools that can be used to determine global patterns of activity for the papain family of cysteine proteases based on the broad reactivity of the natural product E-64. These tools provide functional information that can be used in concert with existing ge- nomic and proteomic methods to correlate gene and protein expression pro¢les with enzymatic activity. Furthermore, diversi¢cation of core compounds using solid-phase combinatorial chemistry provides libraries of compounds that can be used to obtain information about inhibitor speci¢cities of targeted protease. This information is likely to be of use in the generation of selective inhibitors without the need for prior characterization and puri¢cation of protease targets. Finally, the probes themselves can be used to rapidly identify targets after covalent modi¢cation.
Results and discussion
Design and synthesis of DCG-04
The natural product E-64 is a promiscuous irreversible cysteine protease inhibitor that is broadly reactive toward the papain family of cysteine proteases [20] (Figure 1 ). Its leucine side chain mimics the P2 amino acid of a substrate, occupying the target's S2 binding pocket while the agmatine moiety binds in the S3 position [33] . Rich et al. synthesized JPM-565 (Figure 1 ), a derivative in which a tyramine moiety replaces the agmatine side chain of E-64 [34, 35] . This closely related compound was found to have similar class-speci¢c reactivity for cysteine proteases as E-64. Since the P2 position of a substrate is considered to be the main speci¢city determinant for many cysteine proteases, we reasoned that further extension of the nonprime binding portion of JPM-565 would not signi¢cantly perturb binding af¢nity for a target protease. In addition, modi¢cation to the non-prime site binding element of the E-64 derivative CA-074 had little effect on binding to cathepsin B [23, 36] . Elaboration of the peptide portion of E-64 allowed both incorporation of an af¢nity tag as well as attachment of the compound to a solid support. The resulting bi-functional compounds, DCG-03 and DCG-04, contain both the iodinatable phenol ring of JPM-565 and the additional af¢nity site created by incorporation of a side chain biotinylated lysine residue (Figure 1 ). Addition (DCG-04) or removal (DCG-03) of an amino hexanoic acid spacer between the af¢nity site and the electrophile was used to determine the space requirement for binding and recognition of the af¢nity label by support-bound avidin.
Peptide epoxides were synthesized using a combination of solution and solid-phase chemistries. The solution-phase synthesis of the epoxide acid building block (Figure 2A ) starting from commercially available diethyl tartrate has been reported elsewhere [23] . Standard solid-phase peptide chemistry was used to build the peptide portion of DCG-04 and related compounds ( Figure 2B ). This methodology provides a £exible system with which to incorporate virtually any peptide sequence prior to attachment of the electrophilic epoxide. Surprisingly, the epoxy acid building block was stable to standard solid-phase peptide synthesis cleavage conditions (95% TFA). The use of solid-phase chemistry also allowed the synthesis of a diverse library in which the P2 leucine of DCG-04 was replaced with each of the natural amino acids (except cysteine due to reactivity with the epoxide and methionine due to oxidation). The non-natural amino acid norleucine was used as an isosteric methionine analog. The results obtained using this 19 member library of compounds are described below.
DCG-04 is an activity-dependent af¢nity label
Dendritic cells express relatively high levels of lysosomal cathepsins, making them a logical source of material for establishing parameters for the use of DCG-04. Figure 3 shows the labeling pro¢le of polypeptides modi¢ed by incubation with either DCG-03, DCG-04, 125 I-DCG-03 or 125 I-DCG-04 followed by SDS^PAGE analysis. Radio-iodinated (autoradiogram) and non-radio-iodinated (blot) DCG-03 and DCG-04 labeled multiple polypeptides in the range of 20^40 kDa.
Although the intrinsic reactivity of the epoxide electrophile portion of DCG-04 towards free thiols is quite poor, we wanted to determine if DCG-04 and its derivatives were capable of non-speci¢c alkylation of proteins in crude cellular extracts. A pre-heating control was used to reveal nonspeci¢c labeling, with the assumption that denatured, inactive proteins modi¢ed by DCG-03 and DCG-04 represent non-speci¢c modi¢cations. Enzymatically active proteins were deduced by subtraction (Figure 3) . Labeling of all of the major species in the 20^40 kDa size range was lost upon heat denaturation of samples prior to addition of compounds, suggesting that labeling is dependent on enzymatic activity and that these bands correspond to the major proteases in the extract. Several higher molecular weight species were observed by af¢nity blotting of both denaturing controls and samples in which no inhibitor was added. These species are likely to represent non-speci¢c alkylations and endogenously biotinylated proteins.
Comparison of labeling, at neutral (pH 7.4) and at the acidic pH of the lysosome (pH 5.5), indicated that several of the modi¢ed polypeptides in the 30 kDa size range required reduced pH for activity. This result is consistent with reported ¢ndings that several lysosomal cysteine proteases either reversibly or irreversibly lose activity upon de-acidi¢cation of lysosomal compartments [37] .
Analysis of the labeling of DC2.4 lysates by both af¢nity blot and autoradiography techniques resulted in similar pro¢les of modi¢ed polypeptides, highlighting the utility of both techniques. However, the autoradiogram showed labeling of only enzymatically active polypeptides by radiolabeled forms of DCG-03 and DCG-04. Addition of the rather bulky iodine atom to DCG-03 and DCG-04 had only a modest effect on target modi¢cation yet resulted in compounds with dramatically reduced background labeling and increased sensitivity. Ultimately, the ability to use both autoradiography as well as blot techniques enhances the £exibility of these protease detection reagents and further highlights the utility of bi-functional inhibitors.
DCG-04 targets cysteine proteases inhibited by E-64 and JPM-565
Both direct labeling and indirect competition experiments were performed to con¢rm that DCG-04 reacts with a sim- ilar subset of proteases to the parent compounds E-64 and JPM-565. An indirect competition experiment was required to determine the polypeptides modi¢ed by E-64 since it lacks an af¢nity labeling site. Extracts from the dendritic cell line DC2.4 were preincubated with an increasing concentration of E-64 followed by labeling with DCG-04. Final labeling intensity was used to indirectly monitor the extent of polypeptide modi¢cation by E-64. The competition revealed that all polypeptides labeled by DCG-04 are effectively competed by E-64, indicating that the two compounds target the same subset of proteases ( Figure 4A ). A similar competition experiment was performed using the cathepsin B-speci¢c inhibitor MB-074 [23] . These results positively identi¢ed the diffuse 30 kDa polypeptide (labeled cat B in Figure 4A ) as cathepsin B (data not shown).
Comparison of the speci¢city of DCG-03, DCG-04 and JPM-565 was accomplished using direct labeling of DC2.4 cell lysates. Labeling pro¢les obtained for 125 I-DCG-03, 125 I-DCG-04 and 125 I-JPM-565 were identical for all three probes and indicated that each targeted polypeptides in the 20^40 kDa size range ( Figure 4B ). Analysis of non-radiolabeled DCG-03-, DCG-04-and JPM-565-treated extracts again showed the similarity of the blotting and autoradiography detection systems. As expected, JPM-565, which lacks a biotin label, showed no labeling as detected by af¢nity blotting. Together these results establish that modi¢cations to the extended binding portion of the E-64 family of compounds have little effect on selectivity or potency. However, this region of the inhibitor may still play an important role in establishing speci¢city of binding when equipped with the proper recognition sequence. Future work is aimed at exploring the use of extended peptide recognition motifs to ¢ne tune selectivity of the DCG family of inhibitors for speci¢c protease targets.
Pro¢ling applications
The aforementioned methods established the initial parameters for use of the general cysteine protease labels DCG-03 and DCG-04. We next wanted to apply these techniques to pro¢le the activity and speci¢city of cysteine proteases in several different model systems. The broadly reactive probe DCG-04 was used to generate activity pro¢les of multiple protease targets both in a model for disease progression and throughout multiple tissue types. Similarly, activity pro¢les were generated using the cathepsin B-speci¢c probe MB-074 to provide complementary information for a single, well-de¢ned cysteine protease target. This information was also used to positively establish the identity of cathepsin B in the DCG-04 labeling pro- ¢les. To obtain more detailed functional information for DCG-04-modi¢ed proteases, inhibitor speci¢city pro¢les were generated using a library of DCG-04 analogs in total cellular extracts. The same libraries were also used in conjunction with the cathepsin B-speci¢c probe, 125 I-MB-074, as well as with puri¢ed cathepsin H to determine speci¢c-ity pro¢les for individual target proteases. These results are described below.
Pro¢ling across disease progression using DCG-04 and MB-074
The mouse skin model of multi-stage carcinogenesis has been well studied genotypically and phenotypically, has discrete steps in the progression, but lacks information on cysteine protease involvement [38, 39] . The role of cathepsins in tumor biology has mostly focused on cathepsins B and L. Upregulated levels of both cathepsins B and L have been shown to correlate with an invasive phenotype [12, 40] . Furthermore, cathepsins B and L are secreted by many types of tumorigenic cells and treatment of invasive cells with the cysteine protease inhibitor E-64 results in a block in cellular invasion into a synthetic matrix [41, 42] . These data indicate that cathepsins are likely to play an important role in the metastatic process.
Ten cell lines representing various steps in the progression from benign skin cell (C5N) to highly invasive spindle cell carcinomas (Car B and Car C) were used to analyze global changes in activity of cathepsins throughout this multistage carcinogenesis model. The carcinoma progression also includes benign papilloma cell lines P6, PDV and PDV-C57, and more invasive squamous cell carcinoma cell lines B9, A5 and D3. Equal amounts of protein from each cell lysate were labeled with both the broadly reactive probe, 125 I-DCG-04, as well as the cathepsin B-speci¢c probe, 125 I-MB-074 at pH 5.5 ( Figure 5 ). The results show that several protease activities, including cathepsin B, dramatically £uctuate across the panel of cell lines.
The broadly reactive probe 125 I-DCG-04 highlights the activity of several proteases in the lysosomal cysteine protease size range in each of the cell types ( Figure 5A ). The benign cell lines C5N and P6 both contain multiple labeled polypeptides between 28 and 45 kDa; however, the labeling intensity observed for the P6 line is dramatically increased for all polypeptides in this range. Interestingly, the major difference between these cell lines is an activating mutation in the ras gene [43] . It has previously been shown that various classes of proteases, including the cathepsins, are upregulated downstream of Ras; however, these studies were limited to analysis of expression levels of cathepsin B and H [44] . The papilloma cell lines PDV and PDV-C57 show nearly identical patterns of labeling ( Figure 5A ). However, these pro¢les are dramatically different than the pro¢le observed for C5N and P6 lysates. A predominant 30 kDa polypeptide (cathepsin B [45] .
The cathepsin B-speci¢c label 125 I-MB-074 was used to directly examine the pro¢le of cathepsin B activity in the same collection of cells described ( Figure 5B ). This probe has been found to label cathepsin B in a highly speci¢c manner [23] . Labeling of cathepsin B dramatically changed across the pro¢le of cell types with the greatest activity observed for the PDV and PDV-C57 lines. Furthermore, the apparent molecular weight, as well as the sharpness of the cathepsin B, band differed for the benign and spindle cell carcinomas, suggesting that this enzyme is modi¢ed differently in these cell types. This change in migration for cathepsin B may be due to changes in glycosylation or other post-translational modi¢cations. Cathepsin B has been found to exist as different isoforms with differing pIs in various tumor cells as a result of changes in glycosylation and traf¢cking [46] . Changes in the post-translational modi¢cation of cathepsin B are likely to affect the localization of active forms of the enzyme and therefore may play an important role in the control of cathepsin B activity in tumors [46] . Overall, the results obtained from labeling with 125 I-MB-074 further highlight the variability Pro¢ling protease speci¢city using a library of inhibitors To take advantage of the £exibility and ease of synthesis of the DCG-04 family of compounds, we created a small library of compounds in which the peptide recognition portion of the molecule is modi¢ed. It has been proposed that the main speci¢city regions within the active binding site of the cathepsins are S2, S1, S1P and S2P, with S2 containing the main binding pocket [47] . Since the leucine residue of E-64 binds in the critical S2 pocket of many proteases [33] , changes to this residue are likely to have the greatest effect on speci¢city of our inhibitor for a given target. A complete scanning library consisting of 18 natural amino acids and the isosteric methionine analog norleucine was constructed. This library of inhibitors was used to create pro¢les of inhibitor speci¢city for proteases targeted by DCG-04 and MB-074 ( Figure 6 ).
Competition analysis was used to determine the potency of each member of the P2 scanning library towards multiple protease targets. Lysates from DC2.4 cells were preincubated with 50 WM of each of the 19 DCG library members and residual activity measured for multiple proteases using 125 I-DCG-04 ( Figure 6A ). In general, residues containing non-charged aliphatic side chains [isoleucine (I), leucine (L; DCG-04) and norleucine (n)] show the highest activity and the lowest amount of speci¢city across the pro¢le of polypeptides. More interesting was the apparent selectivity of several DCG family compounds for a subset of labeled polypeptides. For example, the valine containing compound competed for polypeptides 1, 2 and cathepsin B but had little effect on the remaining species. In contrast, both the phenylalanine and tyrosine containing compounds showed speci¢city for polypeptides 2, 3, 4 and 5. Furthermore, while the aspartic acid and glycine containing compounds showed relatively poor activity overall, they showed some degree of speci¢city against polypeptide 2. Using these data to simultaneously score inhibitors for potency and selectivity will be valuable for the development of speci¢c inhibitors.
Similar competition experiments were performed with the library of DCG analogs to obtain pro¢les of single proteases. DC2.4 lysates were preincubated with P2 library and then labeled with the cathepsin B-speci¢c compound 125 I-MB-074 ( Figure 6B ). This method allowed analysis of cathepsin B speci¢city in crude extracts. As found in the 125 I-DCG-04 labeling ( Figure 6B) , isoleucine, leucine, valine and norleucine analogs showed the highest activity followed by the aromatic amino acids (W, Y, F) containing compounds. In order to explore speci¢city pro¢les for additional cysteine proteases that could not be speci¢cally labeled in crude extracts, we performed the same competition labeling experiment described above using a puri¢ed enzyme. Preincubation of puri¢ed cathepsin H with the library of compounds followed by 125 I-DCG-04 labeling resulted in a speci¢city pro¢le that was remarkably similar to the pro¢le observed for cathepsin B in crude extracts ( Figure 6C ). While these two proteases are quite different in their biological functions, it is clear from these data that the two have similar inhibitor speci¢city in the S2 pocket.
Since it is unlikely that two distinct proteases will exhibit identical reactivity across a diverse set of inhibitors, it may be possible to use this information from inhibitor libraries to generate`speci¢city ¢ngerprints' for a series of wellcharacterized proteases. Establishment of a database of protease inhibitor pro¢les could potentially be used to establish target identi¢cation by labeling of crude protein mixtures in the presence of compound libraries. Furthermore, extension of this methodology to longer, more diverse peptide substrate analogs may further accentuate the speci¢city differences of closely related protease species.
Pro¢ling across tissue types
Having determined that both DCG-03 and DCG-04 were capable of covalently modifying multiple papain family Figure 7 . Activity pro¢ling of cysteine proteases across tissue types. Labeling of total cellular extracts (100 Wg protein/lane) from rat brain, kidney, liver, prostate and testis with 125 I-DCG-04 at pH 5.5. Samples were analyzed by SDS^PAGE followed by autoradiography. A pre-heating control was included for each tissue type to indicated background labeling.
proteases in extracts generated from several cell lines, we wanted to test the utility of these reagents for pro¢ling protease activity patterns in various tissues. In this way, a crude map of protease activities can be created for each tissue and ultimately the identity of these major species can be determined by virtue of their reactivity towards the DCG-04 af¢nity probe.
Samples of rat brain, kidney, liver, prostate and testis tissue were used to make crude homogenates at the reduced pH of the lysosome (pH 5.5). Samples were labeled with 125 I-DCG-04 and analyzed by SDS^PAGE/autoradiography (Figure 7) . The most intense labeling in the 20^30 kDa size range was observed for kidney and liver tissue, consistent with the known protein processing functions of these organs. Comparison of the labeling pro¢les across tissue samples indicated that while some of the modi¢ed polypeptides were observed in multiple tissues at nearly identical intensities, several polypeptides showed increased or speci¢c activity in a given tissue type. These data are consistent with the ¢ndings that cathepsin expression patterns and activities are differentially regulated across tissue types [48] . In addition, the major species labeled by 125 I-DCG-04 were in the 20^30 kDa size range and are likely to be lysosomal cathepsins such cathepsins B, H and L. To con¢rm this hypothesis, we chose rat kidney as a starting material for the af¢nity puri¢cation of targeted cysteine protease using DCG-04 as an af¢nity tag. The results of this puri¢cation are described below.
Identi¢cation of DCG-04-modi¢ed proteins in rat kidney by af¢nity chromatography
Perhaps the greatest attribute of a functional proteomics tool is its ability to aid in the identi¢cation of targeted proteins. As shown above, rat kidney contains several polypeptides that were ef¢ciently targeted by DCG-04 ( Figure  7) . Three prominently labeled species of 23 kDa, 28 kDa and 30 kDa were identi¢ed in total kidney extract ( Figure  8A ). When subjected to anion exchange chromatography, these polypeptides partitioned over a wide range of the elution gradient as determined by DCG-04 labeling of column fractions ( Figure 8B ). Two pools of fractions were Figure 8 . Af¢nity puri¢cation of DCG-04-targeted proteases from rat kidney. (A) Labeling of total cellular extracts (100 Wg protein/lane) from rat kidney with 50 WM DCG-04 at pH 5.5. Samples were analyzed by SDS^PAGE followed by af¢nity blot. (B) Anion exchange chromatography of rat kidney lysate using a gradient from 0.05 to 1 M NaCl, pH 9.0. Fractions were analyzed by addition of DCG-04 (50 WM) followed by SDS^PAGE and af¢nity blotting. Fractions containing DCG-04-labeled proteins were pooled (fractions 5^7 and fractions 11^13). (C) Pooled fractions were labeled with DCG-04 (50 WM), and DCG-04-modi¢ed proteins bound to a monomeric avidin column, washed with 1 M NaCl, and eluted using 2 mM biotin. A sample of material from pools prior to application to the af¢nity column (PC) along with column £ow through (FT) and biotin elution fractions (E1^E5) were analyzed by SDS^PAGE followed by silver staining. (D) Elutions containing labeled proteins were pooled, volumes reduced and analyzed by 2D IEF electrophoresis followed by silver staining. Spots labeled with numbers were excised and used for sequencing.
chosen based on differences in labeled protein composition. Fractions 7^9 contained predominantly the 23 and 28 kDa species, and fractions 11^13 contained the 23, 28 and 30 kDa species. Modi¢ed proteins were af¢nity-puri¢ed using a monomeric avidin column that has a reduced binding af¢nity for biotin and thus the bound proteins could be competitively eluted with high concentrations of biotin (2 mM). The af¢nity column puri¢ed all DCG-04-modi¢ed polypeptides in both pools as visualized by SDS^PAGE and silver staining of eluted fractions ( Figure 8C ). To further resolve DCG-04-modi¢ed polypeptides, peak fractions were concentrated, separated by 2D SDS^PAGE and visualized by silver staining ( Figure 8D ).
The 30 kDa polypeptide (cat B) yielded a single spot near the acidic end of the gel, while the 28 kDa polypeptide (spot #1) resolved into a streak near the basic end of the gel. The 23 kDa band yielded three distinct spots ranging in pI from acidic to basic (spots #2^5). All spots were excised from the gel and subjected to in-gel trypsin digestion, followed by peptide extraction and analysis by mass spectrometry. The protein amount in the 30 kDa spot was not suf¢cient for unambiguous identi¢cation based on MS data alone. Thus its identity was con¢rmed as cathepsin B by labeling of anion exchange column fractions with the cathepsin B-speci¢c label 125 I-MB-074 [23] (data not shown).
The tryptic mass ¢ngerprint obtained for the 28 kDa band as well as two of the three 23 kDa spots (#2, #3) indicated the presence of cathepsin H. Furthermore, all three digests contained a MH 1429.7 peptide that was sequenced by low energy dissociation analysis (CID; Figure 9 ). The resulting sequence, MGEDSYPYL/IGK, unequivocally matched cathepsin H. The amino-terminus of cathepsin H is heterogeneous, explaining the presence of multiple cathepsin H isoforms at similar molecular weights [49] . In addition, cathepsin H exists as both single chain and twochain isoforms differing by about 5 kDa [49] . Thus, spot #1 is likely to be the single chain form of cat H while spots #2 and #3 may represent heavy chain versions of the twochain isoform.
The remaining 23 kDa spots (#4, #5) did not yield sequence data; however, spot #5 was identi¢ed as cathepsin L based on the tryptic peptides observed in its digest, its size and pI. Thus, DCG-04 successfully identi¢ed the predominant active cysteine proteases in rat kidney as cathepsins B, H and L in agreement with previous studies [48] .
Signi¢cance
Functional proteomics methods are becoming more important as genomics efforts complete the sequences of various organisms. Cravatt and co-workers have established the utility of a functional proteomics tool speci¢c for the serine hydrolase family of proteases [32] . We show here that a general af¢nity label, DCG-04, and its radiolabeled counterpart, 125 I-DCG-04, can be used to pro¢le cysteine protease activities in crude extracts from cells and tissues, as well as throughout multiple stages of a physiological process. Diversi¢cation of the peptide portion of the inhibitor using solid-phase synthesis established the utility of small libraries of compounds for determining pro¢les of inhibitor speci¢city for both characterized and potentially novel enzymes. The information obtained from these libraries provides a starting point for the development of protease-spe- ci¢c inhibitors and also provides functional information about a protease target that may serve as a method for rapid identi¢cation of targets in crude protein mixtures. Furthermore, DCG-04 can be used as an af¢nity puri¢ca-tion reagent to aid in the identi¢cation of proteases selected by virtue of their reactivity towards our electrophilic probes. Target identi¢cation of proteases from crude extracts based on activity pro¢les will assist in the assignment of protein function as well as potentially identify new players in processes such as carcinogenesis. Finally, further diversi¢cation of these reagents is likely to extend their utility for the study of additional physiological processes that are regulated by proteolysis.
Materials and methods
Synthesis of DCG-04, DCG-03 and P2 diverse library Solution-phase synthesis of ethyl (2S,3S)-oxirane-2,3-dicarboxylate. The synthesis of this compound has been reported elsewhere [23] .
Solid-phase synthesis of DCG-04 and DCG-03. The details of the solid-phase synthesis are shown in Figure 2 . All resins and reagents were purchased from Advanced Chemtech (Louisville, KY, USA). Dry Fmoc-Rink amide resin (0.7 mmol/g) was weighed into 1U10 cm columns (Waters). The columns were ¢tted with Te£on stopcocks and connected to a 20 port vacuum manifold (Waters) that was used to drain solvents and reagents from the columns. The resin was swelled using DMF. The Fmoc protecting group was removed (deprotected) by treatment with a 20% piperidine solution in DMF for 15 min. The resin was washed with 3U3 ml of DMF and 3U3 ml of CH 2 Cl 2 .
Fmoc-Lys(biotin)-OH (100 mg, 70 Wmol, 1 eq), DIC (11.4 Wl, 112 Wmol, 1.5 eq), HOBT (15.1 mg, 112 Wmol, 1.5 eq) were dissolved in 2 ml of DMF, added to the resin and the reaction was agitated for 1 h. The resin was washed, and the N-terminal Fmoc group was deprotected. Fmoc-6-aminohexanoic acid (74.2 mg, 210 Wmol, 3 eq), DIC (21.4 Wl, 210 Wmol, 3 eq) and HOBT (28.4 mg, 210 Wmol, 3 eq) were dissolved in 2 ml DMF, and agitated with the resin for 1 h, followed by washing and deprotection of the N-terminal Fmoc group (synthesis of DCG-03 leaves this step out). Fmoc-Tyr(But)-OH (160.8 mg, 350 Wmol, 5 eq), DIC (35.6 Wl, 350 Wmol, 5 eq) and HOBT (47.2 mg, 350 Wmol, 5 eq) were dissolved in 2 ml DMF, and the reaction agitated for 1 h followed by washing and N-terminal Fmoc group deprotection. Fmoc-leucine (61.8 mg, 350 Wmol, 5 eq), DIC (35.6 Wl, 350 Wmol, 5 eq) and HOBT (47.2 mg, 350 Wmol, 5 eq) were dissolved in 2 ml DMF, and the reaction agitated for 1 h. The resin was washed followed by deprotection of the N-terminal Fmoc group. Ethyl (2S,3S)-oxirane-2,3-dicarboxylate (22.4 mg, 140 Wmol, 2 eq), DIC (14.2 Wl, 140 Wmol, 2 eq) and HOBT (18.9 mg, 140 Wmol, 2 eq) were dissolved in 2 ml DMF, and the reaction agitated for 1 h. The resin was washed with 3U3 ml of DMF and 3U3 ml of CH 2 Cl 2 .
The inhibitors were cleaved from the resin using 1 ml of cleavage cocktail (95% TFA, 2.5% water, 2.5% triisopropylsilane). The mix was collected, and the resin washed with 0.5 ml of fresh cleavage cocktail. Ice cold ether (15 ml) was used to precipitate the product. The solid was collected and dissolved in a minimal amount of DMSO. The product was puri¢ed on a C18 reverse phase high performance liquid chromatography (HPLC) column (Waters, Delta-Pak) using a linear gradient of 01 00% water^acetonitrile. Fractions containing the product were pooled, frozen and lyophilized to dryness. The identity of the product was con¢rmed by mass spectrometry. Electrospray mass spectrum: [ A similar protocol was used to synthesize the P2 diverse library except that synthesis was performed using a 96 well manifold (Robbins Scienti¢c). Synthesis was carried out on 20 mg of Rink resin per well, and all coupling conditions were identical to those described above. Each of 18 natural amino acids (except cysteine and methionine) and including norleucine were coupled after addition of the amino hexanoic acid spacer group. All subsequent steps were performed as described above except peptides were used without HPLC puri¢cation due to the fact that products were found to be pure by HPLC analysis. Identity of products was con¢rmed by mass spectrometry. Electrospray mass spectrum: X = Ala calculated [M+H] for C 40 
Radiolabeling of inhibitors
All compounds were iodinated and isolated using the previously reported protocol [23] .
Preparation of cell and tissue lysates
Tissues were Dounce-homogenized in buffer A (50 mM Tris pH 5.5, 1 mM dithiothreitol (DTT), 5 mM MgCl 2 , 250 mM sucrose) and extracts centrifuged at 1100Ug for 10 min at 4³C. The resulting supernatant was centrifuged at 22 000Ug for 30 min at 4³C and ¢nal supernatants used for all labeling experiments. Cells were lysed using glass beads ( 6 104 Wm) in buffer A and supernatants centrifuged at 15 000Ug for 15 min at 4³C. The total protein concentration of the ¢nal supernatants (soluble) was determined by BCA protein quanti¢cation (Pierce).
Labeling of lysates with
125 I-DCG-04, 125 I-DCG-03 and 125 
I-MB-074
Equivalent amounts of radioactive inhibitor stock solutions (approximately 10 6 cpm per sample) were used for all labeling experiments. Samples of lysates (100 Wg total protein in 100 Wl buffer; 50 mM Tris pH 5.5, 5 mM MgCl 2 , 2 mM DTT) were labeled for 1 h at 25³C unless noted otherwise. Samples were quenched by dilution of 4USDS sample buffer to 1U (for one-dimensional (1D) SDS^PAGE) or by dissolving urea to a ¢nal concentration of 9.5 M (for 2D SDS^PAGE).
Gel electrophoresis
1D SDS^PAGE, 2D IEF gels were performed as described [22] .
SDS^PAGE^Western blotting detection of and autoradiography of DCG-04-modi¢ed proteins
Quenched DCG-04-labeled samples were separated by SDS^PAGE (100 Wg/lane) and transferred to nitrocellulose using a semi-dry apparatus. Membranes were blocked using phosphate-buffered saline (PBS) and 5% (w/v) dry milk for 30 min at 25³C. Blots were washed brie£y with PBS/0.2% Tween (PBS^Tween) and treated with avidin-horseradish peroxidase conjugate (VectaStain) in PBS^Tween for 30 min at 25³C. Blots were washed three times with PBS^Tween, treated with ECL reagents (Amersham) and exposed to ¢lm.
Competition labeling experiments
Lysates from the dendritic cell line DC2.4 were prepared at pH 5.5 as described above. Puri¢ed cathepsin H was purchased from Calbiochem (San Diego, CA, USA). Samples of lysates (100 Wg total protein in 100
Wl buffer B; 50 mM Tris pH 5.5, 5 mM MgCl 2 , 2 mM DTT) or puri¢ed cathepsin H (1 Wg protein in 100 Wl buffer A) were preincubated with 50 WM of each library member (diluted from 5 mM DMSO stocks) for 2 h at room temperature. Samples were then labeled by addition of either 125 I-DCG-04 or 125 I-MB-074 to each sample followed by further incubation at room temperature for 1 h. Samples were quenched by the addition of 4Usample buffer to 1U followed by boiling for 5 min. Samples were analyzed by SDS^PAGE followed by autoradiography.
Preparation of mouse carcinoma cell lines
Mouse melanoma cell lines were prepared by a single topical application of 25 Wg of the chemical mutagen dimethylbenzanthracene to the skin of mice followed by biweekly application of 100 WM of the tumor promoter, TPA, over an extended period of time essentially as described [50^52].
Protein identi¢cation of DCG-04-modi¢ed proteins
A soluble fraction of rat kidney lysate (80 mg total protein) was diluted into anion exchange starting buffer (50 mM Tris, 50 mM NaCl, pH 9.0). The lysate was applied to a HitrapQ anion exchange column (Amersham Pharmacia Biotech) and eluted using a linear gradient of 0.05^1 M NaCl, pH 9. An aliquot from each fraction (50 Wl) was incubated with 50 WM DCG-04 at 25³C for 1 h and analyzed on a 12.5% SDS^PAGE gel followed by af¢nity blotting as described above.
The fractions containing peak labeling of the 25^30 kDa bands were pooled, and DCG-04 was added to a ¢nal concentration of 50 WM. Pools were incubated at 25³C for 2 h and then 12 h at 4³C. Unbound inhibitor was removed and buffer was exchanged with PBS using a PD-10 column (Pharmacia). Samples were applied to a monomeric avidin column (1 ml bed volume; Pierce), and the column was washed with 6U1 ml fractions of 1 M NaCl. Bound proteins were eluted with 0.5 ml fractions of 2 mM biotin/100 mM NH 4 HCO 3 buffer. All wash and eluent fractions were analyzed by SDS^PAGE and silver staining. The fractions containing the labeled 25^30 kDa bands were pooled, the volume reduced by lyophilization and solid urea added to 9.5 M along with BME to 5%, NP-40 to 2%, pH 5^7 ampholytes to 1.6% and pH 3.5^10 ampholytes to 0.4%. Samples were applied to IEF tube gels and electrophoresed at 1000 V for 13 h followed by separation in the second dimension on 12.5% SDS^PAGE gels.
The resulting gels were ¢xed in 12% acetic acid/50% methanol stained with silver according to reported protocols [22] . Spots were excised, digested with trypsin and the peptide molecular weight measurements were carried out by matrix-assisted laser desorption ionization-mass spectrometry (PE Voyager DESTR). Sequence determination was performed on a quadrupole time-of-£ight hybrid tandem mass spectrometer (PE QSTAR) equipped with a Protome nanospray source. This instrument affords high resolution and accuracy for mass measurement and the CID data obtained allowed unambiguous sequence determination. Database searches were performed using the Protein Prospector software package (http://prospector.ucsf.edu/).
